Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neurocrine Biosciences
Pharma
Neurocrine's Ingrezza misses in cerebral palsy trial
Just days after an upbeat R&D event, Neurocrine Biosciences has found itself having to report a phase 3 failure.
Angus Liu
Dec 23, 2025 10:20am
Neurocrine taps Wilson Phillips star for tardive dyskinesia push
May 6, 2025 11:16am
Neurocrine's Ingrezza guidance spooks investors
Feb 10, 2025 9:13am
BMS’ Cobenfy tipped to be top dog in growing schizophrenia space
Dec 19, 2024 9:17am
FDA approves Neurocrine's Crenessity for genetic adrenal disease
Dec 16, 2024 11:26am
Neurocrine elevates BD chief to succeed founder and CEO
May 29, 2024 11:42am
